{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:44:57Z","timestamp":1793915097509,"version":"4.8.0"},"reference-count":72,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300118"],"award-info":[{"award-number":["81300118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072138"],"award-info":[{"award-number":["82072138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Doxorubicin (DOX)-related cardiotoxicity has been recognized as a serious complication of cancer chemotherapy. Effective targeted strategies for myocardial protection in addition to DOX treatment are urgently needed. The purpose of this paper was to determine the therapeutic effect of berberine (Ber) on DOX-triggered cardiomyopathy and explore the underlying mechanism. Our data showed that Ber markedly prevented cardiac diastolic dysfunction and fibrosis, reduced cardiac malondialdehyde (MDA) level and increased antioxidant superoxide dismutase (SOD) activity in DOX-treated rats. Moreover, Ber effectively rescued the DOX-induced production of reactive oxygen species (ROS) and MDA, mitochondrial morphological damage and membrane potential loss in neonatal rat cardiac myocytes and fibroblasts. This effect was mediated by increases in the nuclear accumulation of nuclear erythroid factor 2-related factor 2 (Nrf2) and levels of heme oxygenase-1 (HO-1) and mitochondrial transcription factor A (TFAM). We also found that Ber suppressed the differentiation of cardiac fibroblasts (CFs) into myofibroblasts, as indicated by decreased expression of \u03b1-smooth muscle actin (\u03b1-SMA), collagen I and collagen III in DOX-treated CFs. Pretreatment with Ber inhibited ROS and MDA production and increased SOD activity and the mitochondrial membrane potential in DOX-challenged CFs. Further investigation indicated that the Nrf2 inhibitor trigonelline reversed the protective effect of Ber on both cardiomyocytes and CFs after DOX stimulation. Taken together, these findings demonstrated that Ber effectively alleviated DOX-induced oxidative stress and mitochondrial damage by activating the Nrf2-mediated pathway, thereby leading to the prevention of myocardial injury and fibrosis. The current study suggests that Ber is a potential therapeutic agent for DOX-induced cardiotoxicity that exerts its effects by activating Nrf2.<\/jats:p>","DOI":"10.3390\/ijms24043257","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T03:01:45Z","timestamp":1675825305000},"page":"3257","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0318-6715","authenticated-orcid":false,"given":"Yiyang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanliang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashuo","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-0726","authenticated-orcid":false,"given":"Xiuxiu","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An Overview of Doxorubicin Formulations in Cancer Therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2165\/11207510-000000000-00000","article-title":"Pegylated Liposomal Doxorubicin: A Review of Its Use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi\u2019s Sarcoma","volume":"71","author":"Duggan","year":"2011","journal-title":"Drugs"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1179546819866445","DOI":"10.1177\/1179546819866445","article-title":"Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician","volume":"13","author":"Perez","year":"2019","journal-title":"Clin. Med. Insights Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management: Cardiotoxicity of Anticancer Treatments","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrcardio.2016.39","article-title":"Cardiotoxicity of Anticancer Therapy","volume":"13","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse Cardiac Effects of Cancer Therapies: Cardiotoxicity and Arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lfs.2018.03.023","article-title":"Toxicity of Doxorubicin (Dox) to Different Experimental Organ Systems","volume":"200","author":"Pugazhendhi","year":"2018","journal-title":"Life Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111702","DOI":"10.1016\/j.biopha.2021.111702","article-title":"Resveratrol Significantly Improves Cell Survival in Comparison to Dexrazoxane and Carvedilol in a H9c2 Model of Doxorubicin Induced Cardiotoxicity","volume":"140","author":"Monahan","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.01.007","article-title":"Autophagic Dysregulation in Doxorubicin Cardiomyopathy","volume":"104","author":"Bartlett","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin Targets Multiple Players: A New View of an Old Problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular Mechanism of Doxorubicin-Induced Cardiomyopathy\u2014An Update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-015-2786-8","article-title":"Reproductive Hormone Levels and Differential Mitochondria-Related Oxidative Gene Expression as Potential Mechanisms for Gender Differences in Cardiosensitivity to Doxorubicin in Tumor-Bearing Spontaneously Hypertensive Rats","volume":"76","author":"Gonzalez","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"809689","DOI":"10.3389\/fcvm.2021.809689","article-title":"Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway","volume":"8","author":"Liao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative Stress Injury in Doxorubicin-Induced Cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative Stress and Heart Failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol.\u2014Heart Circ. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ehf2.12616","article-title":"Reactive Fibrosis Precedes Doxorubicin-induced Heart Failure through Sterile Inflammation","volume":"7","author":"Tanaka","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1871529X11313020010","article-title":"Oxidative Stress and Transforming Growth Factor-\u03b21-Induced Cardiac Fibrosis","volume":"13","author":"Purnomo","year":"2013","journal-title":"Cardiovasc. Haematol. Disord.-Drug Targets"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","article-title":"NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-\u03921\u2013Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts","volume":"97","author":"Cucoranu","year":"2005","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"108770","DOI":"10.1016\/j.foodres.2019.108770","article-title":"Microalgae Carotenoids Intake: Influence on Cholesterol Levels, Lipid Peroxidation and Antioxidant Enzymes","volume":"128","author":"Cazarin","year":"2020","journal-title":"Food Res. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 Signaling in Oxidative and Reductive Stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Azami, N., Hamzehlou, S., Farahani, M.V., Hushmandi, K., and Ashrafizadeh, M. (2021). Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants, 10.","DOI":"10.3390\/antiox10030349"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejmech.2019.02.027","article-title":"Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application","volume":"167","author":"Salerno","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2013.09.018","article-title":"The Janus face of the heme oxygenase\/biliverdin reductase system in Alzheimer disease: It\u2019s time for reconciliation","volume":"62","author":"Barone","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"104308","DOI":"10.1155\/2013\/104308","article-title":"Nrf2 and Cardiovascular Defense","volume":"2013","author":"Howden","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 System in Development, Oxidative Stress Response and Diseases: An Evolutionarily Conserved Mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jsps.2020.08.022","article-title":"Amlodipine alleviates cisplatin-induced nephrotoxicity in rats through gamma-glutamyl transpeptidase (GGT) enzyme inhibition, associated with regulation of Nrf2\/HO-1, MAPK\/NF-kB, and Bax\/Bcl-2 signaling","volume":"28","author":"Azouz","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/DDDT.S224318","article-title":"Curcumin Attenuates Oxaliplatin-Induced Liver Injury and Oxidative Stress by Activating the Nrf2 Pathway","volume":"14","author":"Lu","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101677","DOI":"10.1016\/j.redox.2020.101677","article-title":"Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis","volume":"36","author":"Fang","year":"2020","journal-title":"Redox Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101771","DOI":"10.1016\/j.redox.2020.101771","article-title":"Songorine Promotes Cardiac Mitochondrial Biogenesis via Nrf2 Induction during Sepsis","volume":"38","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"ref_31","first-page":"557","article-title":"A Review of the Effects of Berberis Vulgaris and Its Major Component, Berberine, in Metabolic Syndrome","volume":"20","author":"Tabeshpour","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1527-3466.2001.tb00068.x","article-title":"Cardiovascular Actions of Berberine","volume":"19","author":"Lau","year":"2006","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fct.2014.10.005","article-title":"Berberine Protects Liver from Ethanol-Induced Oxidative Stress and Steatosis in Mice","volume":"74","author":"Zhang","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejps.2012.03.004","article-title":"Berberine Activates Nrf2 Nuclear Translocation and Protects against Oxidative Damage via a Phosphatidylinositol 3-Kinase\/Akt-Dependent Mechanism in NSC34 Motor Neuron-like Cells","volume":"46","author":"Hsu","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lv, X., Yu, X., Wang, Y., Wang, F., Li, H., Wang, Y., Lu, D., Qi, R., and Wang, H. (2012). Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047351"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"970597","DOI":"10.3389\/fphar.2022.970597","article-title":"Analysis of Clinical Characteristics of Mesalazine-Induced Cardiotoxicity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbamcr.2012.03.008","article-title":"Mitochondrial Dynamics in Heart Disease","volume":"1833","author":"Dorn","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ejhf.1439","article-title":"The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity","volume":"21","author":"Russo","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3389\/fphar.2019.01531","article-title":"Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS\/eNOS\/NO Pathway","volume":"10","author":"He","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2022.08.016","article-title":"Panaxatriol Saponin Ameliorates Myocardial Infarction-Induced Cardiac Fibrosis by Targeting Keap1\/Nrf2 to Regulate Oxidative Stress and Inhibit Cardiac-Fibroblast Activation and Proliferation","volume":"190","author":"Yao","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","article-title":"Preventing and Treating Anthracycline Cardiotoxicity: New Insights","volume":"61","author":"Sawicki","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.034497","article-title":"Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology","volume":"140","author":"Bonaca","year":"2019","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"111679","DOI":"10.1016\/j.biopha.2021.111679","article-title":"Comparative Study on Beneficial Effects of Vitamins B and D in Attenuating Doxorubicin Induced Cardiotoxicity in Rats: Emphasis on Calcium Homeostasis","volume":"140","author":"Awad","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119760","DOI":"10.1016\/j.lfs.2021.119760","article-title":"An Update of the Molecular Mechanisms Underlying Doxorubicin plus Trastuzumab Induced Cardiotoxicity","volume":"280","author":"Anjos","year":"2021","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s12276-020-00541-3","article-title":"Melatonin Prevents Doxorubicin-Induced Cardiotoxicity through Suppression of AMPK\u03b12-Dependent Mitochondrial Damage","volume":"52","author":"Yang","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2010.08.046","article-title":"Berberine Ameliorates TNBS-Induced Colitis by Inhibiting Lipid Peroxidation, Enterobacterial Growth and NF-\u039aB Activation","volume":"648","author":"Lee","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1111\/bph.13791","article-title":"Effects of Ranolazine in a Model of Doxorubicin-Induced Left Ventricle Diastolic Dysfunction: Ranolazine in Anthracycline Cardiotoxicity","volume":"174","author":"Cappetta","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 Inhibitor Empagliflozin Improves Myocardial Strain, Reduces Cardiac Fibrosis and pro-Inflammatory Cytokines in Non-Diabetic Mice Treated with Doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fasebj.4.13.2210154","article-title":"Doxorubicin Cardiotoxicity: Analysis of Prevailing Hypotheses","volume":"4","author":"Olson","year":"1990","journal-title":"FASEB J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0024-3205(00)00990-5","article-title":"Effects by Doxorubicin on the Myocardium Are Mediated by Oxygen Free Radicals","volume":"68","author":"Xu","year":"2001","journal-title":"Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-Induced Cardiotoxicity: Overview of Studies Examining the Roles of Oxidative Stress and Free Cellular Iron","volume":"61","author":"Hrdina","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3329\/bmrcb.v40i2.25226","article-title":"Study on Oxidative Stress and Antioxidant Level in Patients of Acute Myocardial Infarction before and after Regular Treatment","volume":"40","author":"Bashar","year":"2015","journal-title":"Bangladesh Med. Res. Counc. Bull."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"De Geest, B., and Mishra, M. (2021). Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111645"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1083\/jcb.201708007","article-title":"Superoxide Dismutases: Dual Roles in Controlling ROS Damage and Regulating ROS Signaling","volume":"217","author":"Wang","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/0006-2952(80)90050-7","article-title":"Evidence of a Complex between Adriamycin Derivatives and Cardiolipin: Possible Role in Cardiotoxicity","volume":"29","author":"Goormaghtigh","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the Identity of Cardiac Fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The Pathogenesis of Cardiac Fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and Heart Failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative Stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1073\/pnas.91.4.1309","article-title":"Activation of the Human Mitochondrial Transcription Factor A Gene by Nuclear Respiratory Factors: A Potential Regulatory Link between Nuclear and Mitochondrial Gene Expression in Organelle Biogenesis","volume":"91","author":"Virbasius","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1128\/MCB.24.22.9823-9834.2004","article-title":"Architectural Role of Mitochondrial Transcription Factor A in Maintenance of Human Mitochondrial DNA","volume":"24","author":"Kanki","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1074\/jbc.M116.752261","article-title":"NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-Derived 2-like 2 (Nrf2)-Dependent Pathway","volume":"292","author":"Bernard","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Arunachalam, S., Nagoor Meeran, M.F., Azimullah, S., Sharma, C., Goyal, S.N., and Ojha, S. (2021). Nerolidol Attenuates Oxidative Stress, Inflammation, and Apoptosis by Modulating Nrf2\/MAPK Signaling Pathways in Doxorubicin-Induced Acute Cardiotoxicity in Rats. Antioxidants, 10.","DOI":"10.3390\/antiox10060984"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"720076","DOI":"10.3389\/fphar.2022.720076","article-title":"Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment","volume":"13","author":"Kumar","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Park, Y.J., Yang, H.J., Li, W., Oh, Y.-C., and Go, Y. (2022). Menthae Herba Attenuates Neuroinflammation by Regulating CREB\/Nrf2\/HO-1 Pathway in BV2 Microglial Cells. Antioxidants, 11.","DOI":"10.3390\/antiox11040649"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a Target for Protection against Cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.freeradbiomed.2015.07.016","article-title":"Protective Effect of Cilostazol against Doxorubicin-Induced Cardiomyopathy in Mice","volume":"89","author":"Koh","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.biopha.2018.03.089","article-title":"p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy","volume":"102","author":"Sunitha","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"BSR20190229","DOI":"10.1042\/BSR20190229","article-title":"Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2\/HO-1 signaling","volume":"39","author":"Ye","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_70","first-page":"47","article-title":"Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-kB signaling pathways","volume":"11","author":"Khoshhal","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bcpt.13340","article-title":"b-LAPachone ameliorates doxorubicin-induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice","volume":"126","author":"Sanajou","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-015-0820-1","article-title":"\u03b21-Adrenoceptor Stimulation Promotes LPS-Induced Cardiomyocyte Apoptosis through Activating PKA and Enhancing CaMKII and I\u03baB\u03b1 Phosphorylation","volume":"19","author":"Wang","year":"2015","journal-title":"Crit. Care"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3257\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:26:33Z","timestamp":1760120793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":72,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24043257"],"URL":"https:\/\/doi.org\/10.3390\/ijms24043257","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]}}}